cantharidin has been researched along with formononetin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
| Chen, M; Fan, Q; Geng, L; Huang, J; Huang, Z; Li, J; Li, Z; Lin, Y; Liu, P; Lu, S; Stalin, A; Tan, Y; Tao, X; Wu, C; Wu, J; Wu, Z; You, L; Zhang, J; Zhao, C | 1 |
1 review(s) available for cantharidin and formononetin
| Article | Year |
|---|---|
The anti-hepatocellular carcinoma effect of Aidi injection was related to the synergistic action of cantharidin, formononetin, and isofraxidin through BIRC5, FEN1, and EGFR.
Topics: Animals; Cantharidin; Carcinoma, Hepatocellular; ErbB Receptors; Flap Endonucleases; Humans; Liver Neoplasms; Nonprescription Drugs; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Survivin; Zebrafish | 2024 |
1 other study(ies) available for cantharidin and formononetin
| Article | Year |
|---|---|
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |